Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension

NCT00061516 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: BETAXON (levobetaxolol HCl)
DRUG: AZOPT (brinzolamide)

Sponsor

Alcon Research